ID   THB_RAT                 Reviewed;         461 AA.
AC   P18113; P37826;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 2.
DT   02-OCT-2024, entry version 184.
DE   RecName: Full=Thyroid hormone receptor beta;
DE   AltName: Full=Nuclear receptor subfamily 1 group A member 2;
DE   AltName: Full=c-erbA-2;
DE   AltName: Full=c-erbA-beta;
GN   Name=Thrb; Synonyms=Erba2, Nr1a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-1).
RC   TISSUE=Liver;
RX   PubMed=2457590; DOI=10.1016/s0021-9258(18)37820-7;
RA   Murray M.B., Zilz N.D., McCreary N.L., Macdonald M.J., Towle H.C.;
RT   "Isolation and characterization of rat cDNA clones for two distinct thyroid
RT   hormone receptors.";
RL   J. Biol. Chem. 263:12770-12777(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-1).
RC   TISSUE=Pituitary;
RX   PubMed=2899322; DOI=10.1073/pnas.85.14.5031;
RA   Koenig R.J., Warne R.L., Brent G.A., Harney J.W., Larsen P.R., Moore D.D.;
RT   "Isolation of a cDNA clone encoding a biologically active thyroid hormone
RT   receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:5031-5035(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-121 (ISOFORM BETA-2).
RC   TISSUE=Pituitary;
RX   PubMed=2539642; DOI=10.1126/science.2539642;
RA   Hodin R.A., Lazar M.A., Wintman B.I., Darling D.S., Koenig R.J.,
RA   Larsen P.R., Moore D.D., Chin W.W.;
RT   "Identification of a thyroid hormone receptor that is pituitary-specific.";
RL   Science 244:76-78(1989).
RN   [4]
RP   INTERACTION WITH TACC1.
RX   PubMed=20078863; DOI=10.1186/1471-2199-11-3;
RA   Guyot R., Vincent S., Bertin J., Samarut J., Ravel-Chapuis P.;
RT   "The transforming acidic coiled coil (TACC1) protein modulates the
RT   transcriptional activity of the nuclear receptors TR and RAR.";
RL   BMC Mol. Biol. 11:3-3(2010).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF 104-206, AND SUBUNIT.
RX   PubMed=20610536; DOI=10.1210/me.2010-0129;
RA   Chen Y., Young M.A.;
RT   "Structure of a thyroid hormone receptor DNA-binding domain homodimer bound
RT   to an inverted palindrome DNA response element.";
RL   Mol. Endocrinol. 24:1650-1664(2010).
CC   -!- FUNCTION: Nuclear hormone receptor that can act as a repressor or
CC       activator of transcription. High affinity receptor for thyroid
CC       hormones, including triiodothyronine and thyroxine.
CC   -!- SUBUNIT: Binds DNA as a dimer; homodimer and heterodimer with RXRA (By
CC       similarity). Interacts with the coactivators NCOA1/SRC1, NCOA2/GRIP1,
CC       NCOA7 and MED1/TRAP220 in a ligand-inducible manner (By similarity).
CC       Interacts with the corepressor NCOR1 in absence of ligand. Interacts
CC       with C1D (By similarity). Interacts with NR2F6; the interaction impairs
CC       the binding of the THRB homodimer and THRB:RXRB heterodimer to T3
CC       response elements (By similarity). Interacts with PRMT2 and THRSP (By
CC       similarity). Interacts with TACC1; this interaction is decreased in the
CC       presence of thyroid hormone T3 (PubMed:20078863). {ECO:0000250,
CC       ECO:0000269|PubMed:20078863}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-1;
CC         IsoId=P18113-1; Sequence=Displayed;
CC       Name=Beta-2;
CC         IsoId=P18113-2, P37826-1;
CC         Sequence=VSP_031079;
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40916.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA42200.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03933; AAA40916.1; ALT_INIT; mRNA.
DR   EMBL; J03819; AAA60743.1; -; mRNA.
DR   EMBL; M25071; AAA42200.1; ALT_INIT; mRNA.
DR   PIR; A31820; A31820.
DR   PIR; A41355; A41355.
DR   PDB; 3M9E; X-ray; 2.41 A; A/B/E/F=104-206.
DR   PDBsum; 3M9E; -.
DR   AlphaFoldDB; P18113; -.
DR   SMR; P18113; -.
DR   DIP; DIP-61264N; -.
DR   IntAct; P18113; 2.
DR   STRING; 10116.ENSRNOP00000073083; -.
DR   BindingDB; P18113; -.
DR   ChEMBL; CHEMBL3917; -.
DR   DrugCentral; P18113; -.
DR   PhosphoSitePlus; P18113; -.
DR   PaxDb; 10116-ENSRNOP00000008752; -.
DR   ABCD; P18113; 3 sequenced antibodies.
DR   UCSC; RGD:3858; rat. [P18113-1]
DR   AGR; RGD:3858; -.
DR   RGD; 3858; Thrb.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; P18113; -.
DR   PhylomeDB; P18113; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   EvolutionaryTrace; P18113; -.
DR   PRO; PR:P18113; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0070324; F:thyroid hormone binding; ISS:UniProtKB.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; ISO:RGD.
DR   GO; GO:0048568; P:embryonic organ development; IEP:RGD.
DR   GO; GO:0008050; P:female courtship behavior; ISO:RGD.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0007621; P:negative regulation of female receptivity; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IDA:RGD.
DR   GO; GO:0045778; P:positive regulation of ossification; IDA:RGD.
DR   GO; GO:0002157; P:positive regulation of thyroid hormone mediated signaling pathway; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; IMP:RGD.
DR   GO; GO:0008016; P:regulation of heart contraction; ISO:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IDA:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0090207; P:regulation of triglyceride metabolic process; IMP:RGD.
DR   GO; GO:0097474; P:retinal cone cell apoptotic process; ISO:RGD.
DR   GO; GO:0046549; P:retinal cone cell development; ISO:RGD.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0002154; P:thyroid hormone receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; ISO:RGD.
DR   CDD; cd06961; NR_DBD_TR; 1.
DR   CDD; cd06935; NR_LBD_TR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050234; Nuclear_hormone_rcpt_NR1.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001728; ThyrH_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24082; NUCLEAR HORMONE RECEPTOR; 1.
DR   PANTHER; PTHR24082:SF210; THYROID HORMONE RECEPTOR BETA; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   PRINTS; PR00546; THYROIDHORMR.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; DNA-binding; Metal-binding; Nucleus;
KW   Receptor; Reference proteome; Transcription; Transcription regulation;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..461
FT                   /note="Thyroid hormone receptor beta"
FT                   /id="PRO_0000053450"
FT   DOMAIN          217..461
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        107..181
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         107..127
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         145..169
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..106
FT                   /note="Modulating"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          244..461
FT                   /note="Interaction with NR2F6"
FT                   /evidence="ECO:0000250"
FT   BINDING         107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         110
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         124
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         145
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         151
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         161
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         164
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         282
FT                   /ligand="3,3',5-triiodo-L-thyronine"
FT                   /ligand_id="ChEBI:CHEBI:533015"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         282
FT                   /ligand="L-thyroxine"
FT                   /ligand_id="ChEBI:CHEBI:58448"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         331
FT                   /ligand="3,3',5-triiodo-L-thyronine"
FT                   /ligand_id="ChEBI:CHEBI:533015"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         331
FT                   /ligand="L-thyroxine"
FT                   /ligand_id="ChEBI:CHEBI:58448"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         435
FT                   /ligand="3,3',5-triiodo-L-thyronine"
FT                   /ligand_id="ChEBI:CHEBI:533015"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   BINDING         435
FT                   /ligand="L-thyroxine"
FT                   /ligand_id="ChEBI:CHEBI:58448"
FT                   /evidence="ECO:0000250|UniProtKB:P10828"
FT   VAR_SEQ         1..93
FT                   /note="MTPNSMTENRLPAWDKQKPHPDRGQDWKLVGMSEACLHRKSHVERRGALKNE
FT                   QTSSHLIQATWASSIFHLDPDDVNDQSVSSAQTFQTEEKKC -> MNYCVPEVHEVCPA
FT                   AGSNRYMQVTDYLAYLEDSPAYSGCDVQAVPGSSIYLEQAWTLNQPYTCSYPGNLFKSK
FT                   DSDLDMALSQYSQPAHLPEEKPFPQVRSPPHSHK (in isoform Beta-2)"
FT                   /evidence="ECO:0000303|PubMed:2539642"
FT                   /id="VSP_031079"
FT   CONFLICT        9..10
FT                   /note="NR -> KC (in Ref. 2; AAA60743)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263
FT                   /note="Q -> K (in Ref. 2; AAA60743)"
FT                   /evidence="ECO:0000305"
FT   TURN            108..110
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   STRAND          116..122
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   HELIX           125..136
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   TURN            155..159
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   HELIX           162..171
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:3M9E"
FT   HELIX           182..202
FT                   /evidence="ECO:0007829|PDB:3M9E"
SQ   SEQUENCE   461 AA;  52656 MW;  16705C200E02995B CRC64;
     MTPNSMTENR LPAWDKQKPH PDRGQDWKLV GMSEACLHRK SHVERRGALK NEQTSSHLIQ
     ATWASSIFHL DPDDVNDQSV SSAQTFQTEE KKCKGYIPSY LDKDELCVVC GDKATGYHYR
     CITCEGCKGF FRRTIQKSLH PSYSCKYEGK CIIDKVTRNQ CQECRFKKCI YVGMATDLVL
     DDSKRLAKRK LIEENREKRR REELQKSIGH KPEPTDEEWE LIKTVTEAHV ATNAQGSHWK
     QKRKFLPEDI GQAPIVNAPE GGQVDLEAFS HFTKIITPAI TRVVDFAKKL PMFCELPCED
     QIILLKGCCM EIMSLRAAVR YDPDSETLTL NGEMAVTRGQ LKNGGLGVVS DAIFDLGMSL
     SSFNLDDTEV ALLQAVLLMS SDRPGLACVE RIEKYQDSFL LAFEHYINYR KHHVTHFWPK
     LLMKVTDLRM IGACHASRFL HMKVECPTEL FPPLFLEVFE D
//
